Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis

Table 2

Distribution of pathogens isolated from mild and severe cases.

	Total		Mild (n=42)		Severe (n=45)		P
	Bacterial strains (strain)	Proportion (%)	Bacterial strains (strain)	Proportion (%)	Bacterial strains (strain)	Proportion (%)
Gram-negative bacteria	65	74.71	31	73.81	34	75.56	0.9912
E. coli (+)	34	39.08	18	42.86	16	35.56	0.4855
K. pneumoniae (+)	9	10.34	4	9.52	5	11.11	0.8081
E. coli (-)	8	9.2	1	2.38	7	15.56	0.0336
K. pneumoniae (-)	5	5.75	3	7.14	2	4.44	0.5889
Proteus mirabilis	2	2.3	0	0	2	4.44	NA
Stenotrophomonas maltophilia	2	2.3	2	4.76	0	0	NA
Pseudomonas aeruginosa	2	2.3	2	4.76	0	0	NA
Acinetobacter baumannii	1	1.15	0	0	1	2.22	NA
Acinetobacter junii	1	1.15	0	0	1	2.22	NA
Enterobacter cloacae	1	1.15	1	2.38	0	0	NA
Gram-positive bacteria	14	16.09	7	16.67	7	15.54	0.8879
Enterococcus faecium	5	5.75	3	7.14	2	4.44	0.5889
Enterococcus faecalis	1	1.15	1	2.38	0	0	NA
Streptococcus alactolyticus	1	1.15	0	0	1	2.22	NA
Aerococcus viridans	1	1.15	0	0	1	2.22	NA
Human Staphylococcus subgroup	2	2.3	0	0	1	2.22	NA
Staphylococcus epidermidis	1	1.15	1	2.38	1	2.22	NA
Staphylococcus capitis	1	1.15	0	0	1	2.22	NA
Staphylococcus saprophyticus	1	1.15	1	2.38	0	0	NA
Staphylococcus warneri	1	1.15	1	2.38	0	0	NA
Fungi	8	9.2	4	9.52	4	8.89	0.9183
Candida albicans	4	4.6	3	7.14	1	2.22	0.6244
Candida glabrata	1	1.15	1	2.38	0	0	NA
Candida parapsilosis	1	1.15	0	0	1	2.22	NA
Trichosporon asahii	1	1.15	0	0	1	2.22	NA
Candida tropicalis	1	1.15	0	0	1	2.22	NA

(+): ESBL producing; (-): ESBL nonproducing bacterial isolate.